FDA: Real-World Survival With Impella RP Much Worse Than in Trials

(MedPage Today) -- Just 17% in postmarket data, compared with 73% in clinical studies

Source: MedPage Today Surgery - February 4, 2019 Category: Surgery Source Type: news